Media Availability: HIV Antibodies Block Infection by Reservoir-Derived Virus in Laboratory Study

Media Availability: HIV Antibodies Block Infection by Reservoir-Derived Virus in Laboratory Study





Tae-Wook Chun, Ph.D., staff scientist in the NIAID Laboratory of Immunoregulation and first author of the study.
Credit: NIAID
View larger image.

HIV Antibodies Block Infection by Reservoir-Derived Virus in Laboratory Study

A laboratory study led by NIAID scientists lends further weight to the potential effectiveness of passive immunotherapy to suppress HIV in the absence of drug treatment. Passive immunotherapy for HIV is an experimental strategy that involves periodically administering broadly neutralizing HIV-specific antibodies to control the virus.

Read more about this study.